Showing results (201-210 of 212) with videos related to
Sort By:
Pageof 22
Cancer Biotherapy & Radiopharmaceuticals|September 26, 2022
First-In-Human Pilot PET Immunoimaging Study of <sup>64</sup>Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing CancersJeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, et al.The Journal of Biological Chemistry|October 5, 2010
Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanningTove Olafsen, Stephen G Young, Brandon S J Davies, et al.Oncoimmunology|January 9, 2018
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancerSaul J Priceman, Ethan A Gerdts, Dileshni Tilakawardane, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2016
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion UptakeNeeta Pandit-Taskar, Joseph A O'Donoghue, Shutian Ruan, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2021
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunityJohn P Murad, Dileshni Tilakawardane, Anthony K Park, et al.Nature Communications|February 2, 2020
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonistGiulia Parisi, Justin D Saco, Felix B Salazar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion TargetingNeeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.Blood Advances|October 23, 2020
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumabAmrita Krishnan, Vikram Adhikarla, Erasmus K Poku, et al.The Lancet. Oncology|March 1, 2023
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshopLalitha K Shankar, Heiko Schöder, Elad Sharon, et al.Blood Advances|October 12, 2021
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphomaAlex F Herrera, Joycelynne Palmer, Vikram Adhikarla, et al.Pageof 22